UBS raised the firm’s price target on Bath & Body Works to $36 from $32 and keeps a Neutral rating on the shares. The firm expects a low-volume event from the Q1 earnings, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Positive Outlook for Bath & Body Works Amid Strong Financial Performance and Strategic Leadership Changes
- Bath & Body Works price target raised to $42 from $36 at Citi
- Positive Outlook for Bath & Body Works Amid Leadership Change and Strong Q1 Performance
- Bath & Body Works price target raised to $35 from $31 at Barclays
- Bath & Body Works: Strong Earnings and Strategic Leadership Drive Buy Rating